Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Oslo University Hospital has initiated an observational study on hospitalised patients with confirmed COVID-19, the infection caused by Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2).
Description: Fatal outcome from COVID-19
Measure: Death Time: From date of randomization until the date of death from any cause assessed up to 3 months.Description: Resolved infection
Measure: Recovery from COVID-19 Time: From date of randomization until the date of recovery from COVID-19 symptoms assessed up to 3 months.Description: Percentage of patients requiring intensive care admission or ventilation
Measure: Progression to ICU care or ventilation Time: 30 daysDescription: The change in(clearance of) viral RNA measured by polymerase chain reaction assay (PCR) test at days 1, 3, 8,14 and 90 days
Measure: Clearance of SARS-CoV-2 from respiratory specimen Time: The number of calendar days from date of PCR positive test (counted as 1 day) in respiratory specimen until date of such test first become negative in the respiratory specimen assessed up to 3 monthsDescription: Cell-mediated and humoral immunity
Measure: Immune response to COVID-19 Time: From date of randomization until the date of clinical follow-up assessed up to 3 months.